LH
40
-5
CFG
74
2
AMZN
61
-5
KHC
9
-4
XOM
42
-6
MTB
65
-2
UPS
48
2
O
17
-13
MLM
45
-5
DE
42
3
GOOG
57
-6
FSLR
44
-2
PVH
60
-4
MSFT
46
-11
INTC
41
4
USB
50
-3
DAL
84
-3
HAS
30
-2
AMT
37
3
RIG
43
-7
LH
40
-5
CFG
74
2
AMZN
61
-5
KHC
9
-4
XOM
42
-6
MTB
65
-2
UPS
48
2
O
17
-13
MLM
45
-5
DE
42
3
GOOG
57
-6
FSLR
44
-2
PVH
60
-4
MSFT
46
-11
INTC
41
4
USB
50
-3
DAL
84
-3
HAS
30
-2
AMT
37
3
RIG
43
-7
Financhill
Back

Leuthold Core ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
46

LCR
Leuthold Core ETF

Last Price:
35.41
Seasonality Move:
3.08%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.96
Seasonality Move:
17.03%
Sell
46
Leuthold Core ETF (LCR) is a Sell

Is Leuthold Core ETF a Buy, Sell or Hold?

  • The current Leuthold Core ETF [LCR] share price is $35.41. The Score for LCR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • LCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LCR Stock Price Chart

What is Leuthold Core ETF's stock price today?

  • The Leuthold Core ETF share price today is $35.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LCR is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

LCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 49.68 Sell
Chaikin Money Flow: -2723 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.13 - 35.73) Sell
Bollinger Bands (100): (34.1 - 35.4) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

LCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.74 Sell
20-day SMA: 35.39 Buy
50-day SMA: 35.27 Buy
200-day SMA: 33.97 Buy
8-day EMA: 35.6 Sell
20-day EMA: 35.48 Sell
50-day EMA: 35.22 Buy
200-day EMA: 33.99 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Leuthold Core ETF Earnings Growth & LCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Leuthold Core ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):